General practitioners' perceptions of delayed antibiotic prescription for respiratory tract infections: A phenomenographic study

Erika A Saliba-Gustafsson, Marta Röing, Michael A Borg, Senia Rosales-Klintz, Cecilia Stålsby Lundborg, Erika A Saliba-Gustafsson, Marta Röing, Michael A Borg, Senia Rosales-Klintz, Cecilia Stålsby Lundborg

Abstract

Background: Antibiotic use is a major driver of antibiotic resistance. Although delayed antibiotic prescription is a recommended strategy to reduce antibiotic use, practices vary; it appears less commonly used in southern European countries where antibiotic consumption is highest. Despite these variations, few qualitative studies have explored general practitioners' perceptions of delayed antibiotic prescription. We therefore aimed to explore and describe the perceptions of delayed antibiotic prescription for respiratory tract infections among general practitioners in Malta.

Methods: This qualitative phenomenographic study was conducted in Malta. A semi-structured interview guide was developed in English, pilot tested and revised accordingly. Interview topics included views on antibiotic resistance, antibiotic use and delayed antibiotic prescription for respiratory tract infections, and barriers and facilitators to antibiotic prescription. Individual, face-to-face interviews were held in 2014 with a quota sample of 20 general practitioners and transcribed verbatim. Data were subsequently analysed using a phenomenographic approach.

Findings: General practitioners perceived delayed antibiotic prescription in five qualitatively different ways: (A) "The Service Provider"-maintaining a good general practitioner-patient relationship to retain patients and avoid doctor-shopping, (B) "The Uncertainty Avoider"-reaching a compromise and providing treatment just in case, (C) "The Comforter"-providing the patient comfort and reassurance, (D) "The Conscientious Practitioner"-empowering and educating patients, and limiting antibiotic use, and (E) "The Holder of Professional Power"-retaining general practitioner responsibility by employing a wait-and-see approach. Although general practitioners were largely positive towards delayed antibiotic prescription, not all supported the strategy; some preferred a wait-and-see approach with follow-up. Many delayed antibiotic prescription users selectively practiced delayed prescription with patients they trusted or who they believed had a certain level of knowledge and understanding. They also preferred a patient-led approach with a one to three day delay; post-dating delayed antibiotic prescriptions was uncommon.

Conclusions: In this study we have shown that general practitioners hold varying perceptions about delayed antibiotic prescription and that there is variation in the way delayed antibiotic prescription is employed in Malta. Whilst delayed antibiotic prescription is utilised in Malta, not all general practitioners support the strategy, and motivations and practices differ. In high consumption settings, formal and standardised implementation of delayed antibiotic prescription could help curb antibiotic overuse. Diagnosis-specific delayed antibiotic prescription recommendations should also be incorporated into guidelines. Finally, further investigation into patients' and pharmacists' views on delayed antibiotic prescription is required.

Trial registration number: NCT03218930.

Conflict of interest statement

At the time of the study, SRK was employed at Karolinska Institutet, Sweden. She is currently employed by the European Centre for Disease Prevention and Control (ECDC). The views and opinions expressed herein are the authors’ own and do not necessarily state or reflect those of ECDC. ECDC is not responsible for the data and information collation and analysis and cannot be held liable for conclusions or opinions drawn. This does not alter our adherence to PLOS ONE policies on sharing data and materials. EASG, MR, MAB and CSL have declared no competing interests exist.

Figures

Fig 1. The outcome space.
Fig 1. The outcome space.
This figure illustrates how the categories of description relate to each other. They are split into delayed antibiotic prescription (DAP) users and non-users. “Holders of Professional Power” are unwilling to share decision-making and use a wait-and-see strategy. “Conscientious Practitioners”, “Uncertainty Avoiders” and “Comforters” selectively practice DAP; they opt for a wait-and-see approach under certain circumstances, reflecting similarities with “Holders of Professional Power”. “Conscientious Practitioners” represent a deeper level of self-reflection and a higher degree of awareness of DAP as a tool for decreasing antibiotic use. “Services Providers” differ; they are non-selective DAPs users who focus on ensuring patient satisfaction and maintaining a good GP-patient relationship, irrespective of who the patient is or what his/her intentions are.

References

    1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019. January;19(1):56–66. 10.1016/S1473-3099(18)30605-4
    1. European Centre for Disease Prevention and Control. The bacterial challenge: time to react. A call to narrow the gap betwen multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm, Sweden: ECDC; 2009.
    1. European Commission. A European one health action plan against antimicrobial resistance (AMR). Brussels, Belgium: European Commission; 2017.
    1. World Health Organization. Global action plan on antimicrobial resistance. Geneva, Switzerland: WHO; 2015.
    1. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010. May 18;340:c2096 10.1136/bmj.c2096
    1. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005. February 12–18;365(9459):579–87
    1. Gulliford MC, Moore MV, Little P, Hay AD, Fox R, Prevost AT, et al. Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. BMJ. 2016. July 4;354:i3410 10.1136/bmj.i3410
    1. Sharland M, Kendall H, Yeates D, Randall A, Hughes G, Glasziou P, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ. 2005;331:328–9. 10.1136/bmj.38503.706887.AE1
    1. Dyar OJ, Beović B, Vlahović-Palčevski V, Verheij T, Pulcini C, on behalf of ESGAP (the ESCMID [European Society of Clinical Microbiology and Infectious Diseases] Study Group for Antibiotic Policies). How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016;14(4):403–13. 10.1586/14787210.2016.1151353
    1. de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, et al. Prescription strategies in acute uncomplicated respiratory infections: a randomized clinical trial. JAMA Intern Med. 2016. January;176(1):21–9. 10.1001/jamainternmed.2015.7088
    1. Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, et al. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ. 2014;348:g1606 10.1136/bmj.g1606
    1. Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA. 2005. June 22;293(24):3029–35. 10.1001/jama.293.24.3029
    1. Dowell J, Pitkethly M, Bain J, Martin S. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract. 2001. March;51(464):200–5.
    1. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001. February 10;322(7282):336–42. 10.1136/bmj.322.7282.336
    1. Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ. 1999;318:715–16. 10.1136/bmj.318.7185.715
    1. Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997. March 8;314(7082):722–7. 10.1136/bmj.314.7082.722
    1. Høye S, Frich JC, Lindbæk M. Use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey. BMC Fam Pract. 2011. May 18;12:34 10.1186/1471-2296-12-34
    1. McDermott L, Leydon GM, Halls A, Kelly J, Nagle A, White J, et al. Qualitative interview study of antibiotics and self-management strategies for respiratory infections in primary care. BMJ Open. 2017;7:e016903
    1. Francis NA, Gillespie D, Nuttall J, Hood K, Little P, Verheij T, et al. Delayed antibiotic prescribing and associated antibiotic consumption in adults with acute cough. Br J Gen Pract. 2012. September;62(602):e639–46
    1. European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union: ESAC-Net surveillance data. Stockholm: ECDC; 2017.
    1. TNS Opinion & Social. Special eurobarometer 478: antimicrobial resistance. Brussels, Belgium: European Commission; 2018.
    1. Saliba-Gustafsson EA, Dunberger Hampton A, Zarb P, Borg MA, Stålsby Lundborg C. Antibiotic prescribing for respiratory tract complaints in Malta: a 1 year repeated cross-sectional surveillance study. J Antimicrob Chemother. 2019. April 1;74(4):1116–24. 10.1093/jac/dky544
    1. National Antibiotic Committee. Information for Healthcare Professionals [Internet]. [cited 28 Jun 2018]. .
    1. Saliba-Gustafsson EA, Borg MA, Rosales-Klintz S, Nyberg A, Stålsby Lundborg C. Maltese Antibiotic Stewardship Programme in the Community (MASPIC): protocol of a prospective quasiexperimental social marketing intervention. BMJ Open. 2017. September 24;7(9):e017992
    1. Röing M, Holmström IK, Larsson J. A metasynthesis of phenomenographic articles on understandings of work among healthcare professionals. Qual Health Res. 2018. January;28(2):273–91. 10.1177/1049732317719433
    1. Björkman I, Erntell M, Röing M, Stålsby Lundborg C. Infectious disease management in primary care: perceptions of GPs. BMC Fam Pract. 2011. January 11;12:1 10.1186/1471-2296-12-1
    1. Björkman I, Berg J, Röing M, Erntell M, Stålsby Lundborg C. Perceptions among Swedish hospital physicians on prescribing of antibiotics and antibiotic resistance. Qual Saf Health Care. 2010. December;19(6):e8 10.1136/qshc.2008.029199
    1. Rahmner PB, Gustafsson LL, Holmström I, Rosenqvist U, Tomson G. Whose job is it anyway? Swedish general practitioners’ perception of their responsibility for the patient’s drug list. Ann Fam Med. 2010. Jan-Feb;8(1):40–6. 10.1370/afm.1074
    1. Röing M, Hirsch JM, Holmström I. Ways of understanding the encounter with head and neck cancer patients in the hospital dental team: a phenomenographic study. Support Care Cancer. 2006. October;14(10):1046–54. 10.1007/s00520-006-0043-8
    1. Stålsby Lundborg C, Wahlström R, Dall’Alba G. Ways of experiencing asthma management. Variations among general practitioners in Sweden. Scand J Prim Health Care. 1999. December;17(4):226–31. 10.1080/028134399750002458
    1. Marton F. Phenomenography: a research approach to investigating different understandings of reality. J Thought. 1986;21(3):28–49.
    1. Marton F, Booth S. Learning and awareness. Mahwah, NJ: Lawrence Erlbaum; 1997.
    1. Azzopardi-Muscat N, Buttigieg S, Calleja N, Merkur S. Malta: health system review. Health Systems in Transition. 2017;19(1):1–137.
    1. PricewaterhouseCoopers. Healthcare delivery in Malta. Malta: PricewaterhouseCoopers; 2012.
    1. Borg MA, Scicluna EA. Over-the-counter acquisition of antibiotics in the Maltese general population. Int J Antimicrob Agents. 2002. October;20(4):253–7. 10.1016/s0924-8579(02)00194-2
    1. Dahlgren LO, Fallsberg M. Phenomenography as a qualitative approach in social pharmacy research. J Soc Adm Pharm. 1991;8(4):150–6.
    1. Yates C, Partridge H, Bruce C. Exploring information experiences through phenomenography. Libr Inf Res. 2012;36(112):96–119.
    1. Peters S, Rowbotham S, Chisholm A, Wearden A, Moschogianis S, Cordingley L, et al. Managing self-limiting respiratory tract infections: a qualitative study of the usefulness of the delayed prescribing strategy. Br J Gen Pract. 2011. September;61(590):e579–89. 10.3399/bjgp11X593866
    1. Petursson P. GPs’ reasons for “non-pharmacological” prescribing of antibiotics: a phenomenological study. Scand J Prim Health Care. 2005. June;23(2):120–5. 10.1080/02813430510018491
    1. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ. 1998;317:637–42. 10.1136/bmj.317.7159.637
    1. Björnsdóttir I, Hansen EH. Intentions, strategies and uncertainty inherent in antibiotic prescribing. Eur J Gen Pract. 2002;8(1):18–24.
    1. Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003. January 18;326(7381):138 10.1136/bmj.326.7381.138
    1. Arroll B, Goodyear-Smith F, Thomas DR, Kerse N. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? J Fam Pract. 2002. November;51(11): 954–9.
    1. Lum EPM, Page K, Whitty JA, Doust J, Graves N. Antibiotic prescribing in primary healthcare: dominant factors and trade-offs in decision-making. Infect Dis Health. 2018. June;23(2):74–86.
    1. Høye S, Frich J, Lindbœk M. Delayed prescribing for upper respiratory tract infections: a qualitative study of GPs’ views and experiences. Br J Gen Pract. 2010. December;60(581):907–12. 10.3399/bjgp10X544087
    1. Ryves R, Eyles C, Moore M, McDermott L, Little P, Leydon GM. Understanding the delayed prescribing of antibiotics for respiratory tract infection in primary care: a qualitative analysis. BMJ Open. 2016. November 18;6(11):e011882 10.1136/bmjopen-2016-011882
    1. Spurling GKP, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2013;CD004417.
    1. Touboul-Lundgren P, Jensen S, Drai J, Lindbæk M. Identification of cultural determinants of antibiotic use cited in primary care in Europe: a mixed research synthesis study of integrated design “Culture is all around us”. BMC Public Health. 2015. September 17;15:908 10.1186/s12889-015-2254-8
    1. Hofstede G, Hofstede G, Minkov M. Cultures and organisations: software of the mind. New York, USA: McGraw-Hill; 2010.
    1. Gaygısız Ü, Lajunen T, Gaygısız E. Socio-economic factors, cultural values, national personality and antibiotics use: a cross-cultural study among European countries. J Infect Public Health. 2017. Nov-Dec;10(6):755–60. 10.1016/j.jiph.2016.11.011
    1. Borg MA. National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. J Antimicrob Chemother. 2012. March;67(3):763–7. 10.1093/jac/dkr541
    1. Deschepper R, Grigoryan L, Stålsby Lundborg C, Hofstede G, Cohen J, Kelen GVD, et al. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res. 2008. June 6;8:123 10.1186/1472-6963-8-123
    1. Raft CF, Bjerrum L, Arpi M, Jarløv JO, Jensen JN. Delayed antibiotic prescription for upper respiratory tract infections in children under primary care: physicians’ views. Eur J Gen Pract. 2017. December;23(1):190–5. 10.1080/13814788.2017.1347628
    1. Cals JWL, Schot MJC, de Jong SAM, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010. Mar-Apr;8(2):124–33. 10.1370/afm.1090
    1. Llor C, Madurell J, Balagué-Corbella M, Gómez M, Cots JM. Impact on antibiotic prescription of rapid antigen detection testing in acute pharyngitis in adults: a randomised clinical trial. Br J Gen Pract. 2011. May;61(586):e244–51. 10.3399/bjgp11X572436
    1. National Institute for Health and Care Excellence. Respiratory tract infections (self-limiting): prescribing antibiotics [Internet]. 2008 [cited 4 Jul 2018]. .
    1. Mack N, Woodsong C, MacQueen KM, Guest G, Namey E. Qualitative research methods: a data collector’s field guide. North Carolina: Family Health International; 2005.
    1. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. Br J Gen Pract. 2003. November;53(496):871–7.

Source: PubMed

3
Abonnere